Trichopoulos D, Kremastinou J, Tzonou A. Does hepatitis B virus cause hepatocellular carcinoma? In: Armstrong B, Bartsch H, eds. Host Factors in Human Carcinogenesis. Lyon, France: International Agency for Research on Cancer, 1982; IARC Pub. No. 39: 317–32.
Google Scholar
Tomatis L, ed. Cancer: Causes, Occurrence and Control. Lyon, France: International Agency for Research on Cancer 1990; IARC Pub. No. 100: 59–60, 88–94, 151–4.
Google Scholar
International Agency for Research on Cancer. Overall Evaluations of Carcinogenicity: an Updating of IARC Monographs 1–42. Lyon, France: IARC, 1987: IARC Monogr Eval Carcinog Risk Humans, Suppl. 7: 96–9, 272–309.
Google Scholar
Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer, 1987: 3–19.
Google Scholar
Parkin MD, Srivatanakul P, Khlat M, et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48: 323–8.
Google Scholar
Trichopoulos D, Tabor E, Gerety RJ, et al. Hepatitis B and primary hepatocellular carcinoma in a European population. Lancet 1978; ii: 1217–19.
Google Scholar
Beasley R, Lin C, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 32,707 men in Taiwan. Lancet 1981; ii: 1129–33.
Google Scholar
Trichopoulos D, Day N, Kaklamani E, et al. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer 1987; 39: 45–9.
Google Scholar
Tabor E. Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma. In: Tabor E, Di Bisceglie A, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX: Adv Applied Biotech Series 13, 1991: 107–18.
Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. JNCI 1990; 82: 1038–41.
Google Scholar
Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 1974–6.
Google Scholar
Tzonou A, Trichopoulos D, Kaklamani E, Zavitsanos X, Koumantaki Y, Hsieh C-c. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and-D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer 1991; 49: 1–4.
Google Scholar
Austin H. The role of tobacco use and alcohol consumption in the etiology of hepatocellular carcinoma. In: Tabor E, Di Bisceglie A, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX: Adv Applied Biotech Series 13, 1991: 57–75.
International Agency for Research on Cancer. Alcohol and Alcoholic Beverages. Lyon, France: IARC, 1988: IARC Monogr Eval Carcinog Risk Humans, Vol. 44: 1–416.
Google Scholar
Henderson B, Preston-Martin S, Edmonson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983; 48: 437–40.
Google Scholar
Neuberger J, Forman D, Doll R, Williams R. Oral contraceptives and hepatocellular carcinoma. Br J Cancer 1986; 292: 1355–7.
Google Scholar
Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br J Cancer 1986; 292: 1357–61.
Google Scholar
Palmer JL, Rosenberg L, Kaufman DW, Warshauer ME, Stolley P, Shapiro S. Oral contraceptive use and liver cancer. Am J Epidemiol 1989; 130: 878–82.
Google Scholar
La Vecchia C, Negri E, Parazzini F. Oral contraceptives and primary liver cancer. Br J Cancer 1989; 59: 460–1.
Google Scholar
The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Combined oral contraceptives and liver cancer. Int J Cancer 1989; 43: 254–9.
Google Scholar
Vall Mayans M, Calvet X, Bruix J, et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990; 46: 378–81.
Google Scholar
Kew MC, Song E, Mohammed A, Hodkinson J. Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case-control study in South African black women. Hepatology 1990; 11: 298–302.
Google Scholar
Thomas DB. Exogenous steroid hormones and hepato-cellular carcinoma. In: Tabor E, Di Bisceglie A, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepato-cellular Carcinoma in North America. Houston, TX: Adv Applied Biotech Series 13, 1991; 77–89.
Hsing A, Hoover R, McLaughlin J, et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992; 3: 43–48.
Google Scholar
Stanford J, Thomas D, and the WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Reproductive factors in the etiology of hepatocellular carcinoma. Cancer Causes Control 1992; 3: 37–42.
Google Scholar
Blumberg BS. The hepatitis B virus. Public Health Rep 1980; 95: 427–35.
Google Scholar
Kew MC. The possible etiologic role of hepatitis-B virus in hepatocellular carcinoma: evidence from Southern Africa. In: Chisari FV, ed. Advances in Hepatitis Research. New York: Masson, 1984; 203–15.
Google Scholar